SAN MATEO, Calif., Aug. 26, 2020 /PRNewswire/ -- Today, the Silicon Valley Recovery Roundtable (SVRR) released the final report, "Building a Better Normal." The report outlines a series of recommendations designed to aid Silicon Valley's recovery from the economic fallout of the COVID-19 pandemic. As Focus Area Co-Chair, Lumiata CEO, Dilawar Syed helped lead a group of business leaders tasked with developing recommendations for small businesses and startups who have borne the brunt of the economic hardship due to the pandemic. "I am most proud that we centered our work around small business and early-stage startups," said Syed. "The aspirations and concerns of founders building the next generation of products must inform policy if we want to preserve Silicon Valley's entrepreneurial core and global leadership in innovation."
San José Mayor Sam Liccardo convened the SVRR to define the most pressing challenges facing the community and identify a set of practical and ambitious solutions. The final 72-page report concentrates on four areas and includes over 25 policy recommendations and practical strategies to help Silicon Valley get families back to work, provide support for small businesses, and ensure the most vulnerable residents are able to fully participate in our recovery.
"It's important to me that diverse communities across Silicon Valley are not left behind in this economic recovery effort," said Jorge Zendejas, a software developer at Lumiata. "I was proud to see our CEO lead the effort that placed so much emphasis on equity."
About Silicon Valley Recovery Roundtable Silicon Valley Recovery Roundtable (SVRR) is a body of leaders across sectors tasked with making policy recommendations to local and regional governing bodies that ensures political leaders harness state and federal resources, get families back to work, and ready for the economy's "new normal." Follow SVRR on Twitter @SVRecovery.
About Lumiata Based in the heart of Silicon Valley, Lumiata is an Artificial Intelligence company that helps healthcare organizations manage costs and risks. Lumiata's predictive power is generated from more than 100 million patient records, in-depth clinical knowledge, and IP. The company has over 100 pre-trained AI models that address a breadth of use cases. Lumiata AI Studio is a productivity tool for data scientists to quickly create and deploy AI models. Lumiata is backed by BlueCross BlueShield Venture Partners, Khosla Ventures and Intel Capital. Visit lumiata.com and follow on Twitter @lumiata.